10 Best Healthcare Technology Stocks To Invest In Right Now

A new report from the Economic Policy Institute, a left-leaning think tank, takes aim at 401(k)s, claiming their poor design was an “accident of history” and that it exacerbates income inequality in retirement.

“Though assets in individual and pooled retirement funds have grown faster than income in recent decades, aggregates and averages can be misleading,” the report says.

Calling it “retirement insecurity,” the institute argues it’s worsened for most Americans as retirement wealth has become more unequal. For many groups, the median household has no savings in retirement accounts, and balances are low even when focusing only on households with savings.

“In 1980, a benefit consultant working on revamping a bank’s cash bonus plan had the idea of adding an employer matching contribution and taking advantage of an obscure provision in the tax code passed two years earlier clarifying the tax treatment of deferred compensation,” the report explains. “Though 401(k)s took off in the early 1980s, Congress did not intend for them to replace traditional pensions as a primary retirement vehicle, and 401(k)s are poorly designed for this role.”

5 Best Gas Utility Stocks For 2015: Agenus Inc.(AGEN)

Agenus Inc., a biotechnology company, engages in developing and commercializing technologies to treat cancers and infectious diseases. It offers Oncophage vaccine for the treatment of adjuvant renal cell carcinoma. The company?s products under development include Prophage series of cancer vaccines, which has been tested in Phase III clinical trials for the treatment of renal cell carcinoma (RCC) and metastatic melanoma, as well as has been tested in Phase I and Phase II clinical trials in various indications; and under Phase II clinical trials in glioma, a type of brain cancer, and adjuvant renal cell carcinoma. The Prophage series of cancer vaccines include R-series candidates in RCC, M-series candidates in melanoma, and G-series candidates in glioma. Its product candidate portfolio includes QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and shingles, as well as in for the treatment of va rious infectious diseases and Alzheimer?s disease; and HerpV that completed Phase 1 clinical trial for the treatment of genital herpes. The company was formerly known as Antigenics Inc. and changed its name Agenus Inc. in January 2011 to reflect its existing product pipeline. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Advisors' Opinion:

• [By Monica Gerson]

  © 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Most Popular Are Massive Xbox One 'Titanfall' Sales To Blame For Xbox 360 Game Delay? Warren Buffett's Conflicting Bitcoin Views Marijuana Econom
• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Smith On Stocks]

  I am initiating coverage of Agenus (AGEN) with a Buy. I have just published a basic report on my website, which goes into detail on the company's two core technology platforms: (1) the heat shock protein technology that is the basis of therapeutic and preventive vaccines for cancer and infectious disease, and (2) the QS-21 Stimulon adjuvant that is being used by Agenus and other vaccine developers to enhance the effectiveness of their vaccines. This report is a summary of that more detailed report.

• [By Lisa Levin]

  Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

  Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

10 Best Healthcare Technology Stocks To Invest In Right Now: C.H. Robinson Worldwide Inc.(CHRW)

C.H. Robinson Worldwide, Inc., a third-party logistics company, provides multimodal freight transportation services and logistics solutions to companies in various industries worldwide. It offers freight transportation services through its contractual relationships with various transportation companies, including motor carriers, railroads, air freight carriers, and ocean carriers. The company has contractual relationships with approximately 49,000 transportation companies. Its transportation and logistics services include truckload, less-than-truckload, intermodal, ocean, and air freight transportation, as well as transportation management, customs brokerage, and warehousing services. In addition, it engages in buying, selling, and marketing fresh produce to grocery retailers, restaurants, produce wholesalers, and foodservice distributors under the Fresh 1 and OurWorld Organics names, as well as under Tropicana, Welch?s, Mott?s, and Glory Foods names. Further, the company provides spend management and payment processing services through a platform that facilitates funds transfer, vendor payments, fuel purchasing, and online expense management primarily for motor carriers and truck stop chains. It operates through a network of 232 branch offices in North America, Europe, Asia, South America, Australia, and the Middle East. C.H. Robinson Worldwide, Inc. was founded in 1905 and is headquartered in Eden Prairie, Minnesota.

Advisors' Opinion:

• [By Russ Fischer]

  CH Robinson Worldwide (CHRW)

  Transportation sector. C.H. Robinson Worldwide, Inc., a third-party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. It also engages in buying, selling, and marketing fresh produce. Yield: 2.5%

• [By Arie Goren]

  After running this screen on May 21, 2013, before the markets' open, I discovered the following eight stocks: Sunoco Logistics Partners LP (SXL), Leggett & Platt Inc (LEG), Copa Holdings SA (CPA), RPC Inc. (RES), Tupperware Brands Corp. (TUP), Herbalife Ltd. (HLF), John Wiley & Sons Inc. (JW.A) and C.H. Robinson Worldwide Inc. (CHRW).

• [By Jake L'Ecuyer]

  CH Robinson Worldwide (NASDAQ: CHRW) was down, falling 8.99 percent to $53.37 after the company reported downbeat Q4 results.

  Commodities
  In commodity news, oil traded up 0.07 percent to $97.26, while gold traded up 0.60 percent to $1,258.70.

• [By Jonathan Yates]

  Not as well known, but just as well-placed to profit from increasing exports, is C.H. Robinson Worldwide (NASDAQ: CHRW).

  Based in Minnesota, C.H. Robinson Worldwide offers global transportation services. It�is one of the largest holdings of Mairs & Power Growth, an excellent mutual fund that has a fondness for companies in Minnesota. Others include Hormel (NYSE: HRL) and 3M (NYSE: MMM). That is fine company for a medium cap like C.H. Robinson Worldwide to be associated with.

10 Best Healthcare Technology Stocks To Invest In Right Now: Blackrock Corporate High Yield Fund Inc (HYT)

BlackRock Corporate High Yield Fund VI, Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income by investing primarily in a diversified portfolio of fixed-income securities.

The investments are rated in the lower rating categories of the rating services (Ba or lower by Moody's Investors Service, Inc., or BB or lower by Standard & Poor's Corporation) or are unrated securities of comparable quality. BlackRock Advisors, LLC. is the manager of the Fund.

Advisors' Opinion:

• [By Aaron Levitt]

  MMT comes with a hefty 6.76% distribution yield and is currently trading for a nearly 12% discount to its underlying value. That�� well over the normal discount range for the fund. �Expenses for MMT run 1.00% — or $100 per $10,000 invested — per year.

  BlackRock Corporate High Yield Fund (HYT)

  Discount to NAV: 7.11%
  Distribution Yield: 7.86%

10 Best Healthcare Technology Stocks To Invest In Right Now: Elisa Oyj (ELI1V)

Elisa Oyj is a Finland-based Company engaged in the provision of Information and Communication Technology (ICT) services in Finland and Estonia. The Company operates within two business segments: Consumer Customers and Corporate Customers. The Consumer Customers segment provides consumers and households with telecommunications services, such as voice and data services. The Corporate Customers segment provides to the corporate and community customers voice and data services, ICT solutions and contact center services. All the services are provided under the Elisa and Saunalahti brands. The Company�� global alliance partners are Vodafone and Telenor. The Company operates through its subsidiaries, including Appelsiini Finland Oy, Arediv Oy, Ecosite Oy and Elisa Eesti As, among others. Advisors' Opinion:

• [By Adam Ewing]

  A sale would provide the shareholders with cash, while potentially strengthening DNA against larger rivals Elisa Oyj (ELI1V) and TeliaSonera AB. (TLSN) The IPO could be the biggest in Finland, home of Nokia Oyj (NOK1V) and ��ngry Birds��maker Rovio Entertainment Oy, since 2005.

10 Best Healthcare Technology Stocks To Invest In Right Now: ChannelAdvisor Corp (ECOM)

Channeladvisor Corporation, incorporated on June 18, 2001, is a provider of software-as-a-service, or SaaS, solutions that enables retailers and manufacturer customers to integrate, manage and optimize their merchandise sales across hundreds of online channels. Through the Company�� platform, the Company enables its customers to connect with new and existing sources of demand for their products, including e-commerce marketplaces, such as eBay, Amazon and Newegg, search engines and comparison shopping websites, such as Google, Microsoft�� Bing, and Nextag, and emerging channels, such as Facebook and Groupon.

The Company serves customers across a range of industries and geographies. As of December 31, 2012, the Company had over 1,900 customers worldwide. Its customers include both traditional and online retailers, such as Ann Taylor, eBags.com, J&R Electronics and Jos. A. Bank Clothiers, as well as manufacturers of consumer goods, such as Dell, Dooney and Bourke, Lenovo, Sony and Under Armour.

The Company�� suite of SaaS solutions allows its customers to more easily integrate, manage and optimize their online sales across hundreds of available channels through a single, integrated platform. Its suite solutions includes a number of individual offerings, or modules. Each module integrates with a particular type of channel, such as third-party marketplaces, paid search or comparison shopping websites, or supports specific online functionality, such as creating webstores or employing rich media solutions on their websites. The Company provides its customers with a single Web-based interface as the central location for them to control, analyze and manage their online sales across hundreds of available channels and multiple geographies. It provides its customers with actionable insights across the latest channel and consumer trends and general product performance, which enables them to evaluate and, if necessary, improve the efficiency of their business rules on existing or new! channels.

Advisors' Opinion:

• [By David Zeiler]

  5. ChannelAdvisor Corp. (NYSE: ECOM): ChannelAdvisor provides web-based merchandise management software to businesses like retailers and manufacturers. ECOM (get it, e-commerce) went public May 23 at $14 a share and rose 31.7% on its first day. It currently trades at about $37.57, putting it up 168.36% over its offer price.

• [By Garrett Cook]

  ChannelAdvisor (NYSE: ECOM) shares shot up 4.40 percent to $24.18. Deutsche Bank upgraded Channel Advisor from Hold to Buy. ChannelAdvisor is expected to release its Q2 financial results on August 4, 2014.

10 Best Healthcare Technology Stocks To Invest In Right Now: First Trust Large Cap Growth AlphaDEX Fund (FTC)

First Trust Large Cap Growth AlphaDEX Fund (the Fund), formerly First Trust Large Cap Growth Opportunities AlphaDEX Fund, is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield of an equity index called the Defined Large Cap Growth Index (the Index). The Index is an enhanced index created and administered by Standard & Poor��, which employs the AlphaDEX stock selection methodology to select stocks from the S&P 500 Growth Index. Standard & Poor�� constructs the Defined Large Cap Growth Index by ranking the stocks from the S&P 500 Growth Index against all the stocks in the S&P 500 Index on growth factors including 3, 6 and 12-month price appreciation, sales to price and one year sales growth, and separately on value factors, including book value to price, cash flow to price and return on assets. First Trust Advisors L.P. is the adviser of the Fund. Advisors' Opinion:

• [By reports.droy]

  Dollar General�� management still remains optimistic as they have remarked that the ��nti-trust issues��are manageable. Company sources have confirmed that on September 2, the management has sweetened the proposal and send it to the Board of Directors of Family Dollar Stores. Under the terms of the revised proposal, Dollar General is ready to increase the bid to $80 per share in an all-cash deal. To further pacify the Family Dollar top brass, Dollar General�� management has agreed to divest nearly 1500 outlets if ordered by the Federal Trade Commission (FTC), from the 700 store divestiture commitment given during the initial bid.

10 Best Healthcare Technology Stocks To Invest In Right Now: Salient MLP And Energy Infrastructure Fund (SMF)

Salient MLP and Energy Infrastructure Fund (the Fund), is an organized, non-diversified, closed-end management investment company. Its investment objective is to provide a high level of total return with an emphasis on making quarterly cash distributions (Distributions) to its shareholders. The Fund seeks to provide its shareholders with a tax-efficient vehicle to invest in a portfolio of energy infrastructure companies that own midstream and other energy assets. The Fund will invest at least 80% of its total assets in securities of companies in the Midstream/Energy Sector, consisting of Midstream MLPs, Midstream Companies, Other MLPs and Other Energy Companies. It will invest in equity securities, such as common units, preferred units, subordinated units, general partner interests, common shares, preferred shares and convertible securities in MLPs, Midstream Companies and Other Energy Companies. The Fund is managed by Salient Capital Advisors, LLC. Advisors' Opinion:

• [By Eric Lam]

  Semafo (SMF) jumped 4.8 percent to C$2.60 and Iamgold gained 2.1 percent to C$4.20 as 21 of 24 members of the S&P/TSX Gold Index increased. Gold rose from a five-month low as investors weighed the outlook for reduced U.S. stimulus as early as next week against speculation physical demand may increase at lower prices. Gold for February delivery advanced 0.6 percent in New York.